Heri blev Ariclaim (hovedsagelig i en dosis på 40 mg to gange dagligt) sammenlignet med placebo (uvirksom behandling).
The four main studies involved 1,913 women and lasted 12 weeks, comparing Ariclaim (mostly as 40 mg twice a day) with placebo (a dummy treatment).